FY2025 EPS Estimates for Enhabit, Inc. Reduced by Leerink Partnrs (NYSE:EHAB)

Enhabit, Inc. (NYSE:EHAB - Free Report) - Investment analysts at Leerink Partnrs lowered their FY2025 EPS estimates for shares of Enhabit in a research note issued on Tuesday, May 14th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $0.12 per share for the year, down from their previous forecast of $0.13. Leerink Partnrs currently has a "Hold" rating on the stock. The consensus estimate for Enhabit's current full-year earnings is $0.24 per share. Leerink Partnrs also issued estimates for Enhabit's FY2026 earnings at $0.05 EPS and FY2027 earnings at ($0.09) EPS.

Enhabit (NYSE:EHAB - Get Free Report) last released its quarterly earnings results on Wednesday, March 6th. The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.01. The company had revenue of $260.60 million for the quarter, compared to analysts' expectations of $260.30 million. Enhabit had a positive return on equity of 1.43% and a negative net margin of 7.95%. During the same period in the prior year, the firm earned $0.32 earnings per share.

Several other brokerages have also recently issued reports on EHAB. Jefferies Financial Group cut Enhabit from a "buy" rating to a "hold" rating and reduced their price objective for the company from $14.00 to $8.75 in a research note on Thursday, May 9th. Oppenheimer reiterated a "market perform" rating on shares of Enhabit in a research note on Thursday, March 7th. SVB Leerink upgraded shares of Enhabit from an "underperform" rating to a "market perform" rating and set a $8.50 target price on the stock in a research note on Tuesday. Finally, UBS Group upgraded shares of Enhabit from a "sell" rating to a "neutral" rating and set a $9.50 price target for the company in a research note on Thursday, March 7th. One equities research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $10.13.

Enhabit Trading Down 3.6 %

NYSE:EHAB traded down $0.31 on Thursday, reaching $8.35. 697,881 shares of the company's stock were exchanged, compared to its average volume of 597,172. The business has a fifty day moving average of $10.38 and a 200-day moving average of $10.05. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.75. Enhabit has a 52-week low of $7.12 and a 52-week high of $14.59. The firm has a market capitalization of $418.75 million, a price-to-earnings ratio of -5.03, a price-to-earnings-growth ratio of 1.41 and a beta of 1.98.

Institutional Investors Weigh In On Enhabit

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. SummerHaven Investment Management LLC raised its position in Enhabit by 1.8% in the 4th quarter. SummerHaven Investment Management LLC now owns 58,947 shares of the company's stock valued at $610,000 after purchasing an additional 1,038 shares during the last quarter. Brooks Moore & Associates Inc. raised its holdings in shares of Enhabit by 5.1% in the third quarter. Brooks Moore & Associates Inc. now owns 26,950 shares of the company's stock valued at $303,000 after buying an additional 1,300 shares during the last quarter. Oppenheimer & Co. Inc. grew its holdings in shares of Enhabit by 7.2% during the first quarter. Oppenheimer & Co. Inc. now owns 26,224 shares of the company's stock worth $306,000 after buying an additional 1,768 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Enhabit by 13.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 16,058 shares of the company's stock valued at $166,000 after acquiring an additional 1,875 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its stake in Enhabit by 5.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 37,950 shares of the company's stock valued at $443,000 after acquiring an additional 2,078 shares during the last quarter.

Insider Transactions at Enhabit

In related news, Director Jeffrey Bolton acquired 10,000 shares of the firm's stock in a transaction on Friday, May 10th. The stock was bought at an average price of $8.24 per share, for a total transaction of $82,400.00. Following the completion of the purchase, the director now directly owns 42,299 shares of the company's stock, valued at approximately $348,543.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.90% of the company's stock.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.